Amlodipine Elimination Time from the Body
Amlodipine has a long terminal elimination half-life of 30-50 hours, requiring approximately 5-7 days (5-7 half-lives) for complete elimination from the body after discontinuation. 1
Pharmacokinetic Profile of Amlodipine
Half-life and Elimination
- Amlodipine exhibits a biphasic elimination pattern with a terminal elimination half-life of approximately 30-50 hours 1
- Complete elimination of a drug typically takes 5-7 half-lives, meaning amlodipine requires 5-7 days (150-350 hours) to be fully cleared from the system 1, 2
- Steady-state plasma levels are reached after 7-8 days of consecutive daily dosing, reflecting this long elimination period 1
Metabolism and Excretion
- Amlodipine is extensively metabolized in the liver (about 90% converted to inactive metabolites) 1
- Approximately 10% of the parent compound and 60% of metabolites are excreted in urine 1
- The drug is highly protein-bound (93% bound to plasma proteins in hypertensive patients) 1, 3
Factors Affecting Elimination Time
Patient-Specific Factors
- Age: Elderly patients have decreased clearance of amlodipine with a resulting increase in AUC of approximately 40-60% 1
- Hepatic function: Patients with hepatic insufficiency have decreased clearance and longer elimination times 1
- The plasma elimination half-life is extended to approximately 56 hours in patients with impaired hepatic function 1
- Heart failure: Patients with moderate to severe heart failure show increased AUC similar to elderly patients 1
Renal Function
- The pharmacokinetics of amlodipine are not significantly influenced by renal impairment 1
- Patients with renal failure may receive the usual initial dose without adjustment for elimination concerns 1
Clinical Implications of Amlodipine's Long Half-Life
Persistent Antihypertensive Effect
- The long elimination half-life contributes to a prolonged antihypertensive effect that extends beyond 24 hours 4
- Research has shown that blood pressure does not significantly increase even after 3 days of medication discontinuation 4
- This extended duration of action provides a buffer against missed doses, maintaining blood pressure control 2, 4
Adherence Testing Considerations
- In chemical adherence testing for hypertension medications, amlodipine's slow clearance means it can be analytically positive up to a week after the last ingestion 5
- This characteristic can make it difficult to distinguish between regular and sporadic dosing in adherence monitoring 5
Drug Interactions During Elimination Period
- As a CYP3A substrate, strong CYP3A inhibitors may increase amlodipine plasma concentrations and potentially extend elimination time 1
- Amlodipine itself is a weak inhibitor of CYP3A and may affect the elimination of other drugs metabolized by this pathway 1
Practical Considerations
Discontinuation Protocol
- Due to the gradual elimination, abrupt discontinuation of amlodipine does not typically cause rebound hypertension 2
- When switching to another antihypertensive medication, the persistent effect of amlodipine should be considered during the transition period 4